Murilo Freitas – Página 55

Reuse Tracheostomy Tubes or Switch to Appropriate Alternatives During Shortage: FDA Safety Communication

Murilo Freitas - 04:00, 30 de octubre de 2022531

The FDA recommends using the following strategies to reduce the number of tracheostomy tubes used per patient during the shortage.

http://www.fda.gov/medical-devices/safety-communications/reuse-tracheostomy-tubes-or-switch-appropriate-alternatives-during-shortage-fda-safety-communication

rss-es

Consider Alternatives for MRI-Guided Breast Biopsy Grid Plates Due to Shortage – Letter to Health Care Providers

Murilo Freitas - 04:00, 30 de octubre de 2022582

The FDA recommends health care providers discuss alternatives for MRI-guided breast biopsies with patients due to shortage of Philips Invivo plates and disposables.

http://www.fda.gov/medical-devices/letters-health-care-providers/consider-alternatives-mri-guided-breast-biopsy-grid-plates-due-shortage-letter-health-care-providers

rss-es

FDA Roundup: October 28, 2022

Murilo Freitas - 20:27, 27 de octubre de 2022479

FDA Roundup: October 28, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-28-2022

rss-es

FDA Denies Marketing of Logic’s Menthol E-Cigarette Products Following Determination They Do Not Meet Public Health Standard

Murilo Freitas - 16:27, 25 de octubre de 2022471

FDA Denies Marketing of Logic’s Menthol E-Cigarette Products Following Determination They Do Not Meet Public Health Standard
http://www.fda.gov/news-events/press-announcements/fda-denies-marketing-logics-menthol-e-cigarette-products-following-determination-they-do-not-meet

rss-es

FDA Roundup: October 25, 2022

Murilo Freitas - 20:47, 24 de octubre de 2022506

FDA Roundup: October 25, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-25-2022

rss-es

Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Recall of Two (2) Lots of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, Due to the Detection of N-Nitroso Quinapril Impurity

Murilo Freitas - 04:00, 24 de octubre de 2022471

East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the consumer level from the US market due to presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-recall-two-2-lots-quinapril-and

rss-es

Do Not Use Certain Mighty Bliss Electric Heating Pads Due to Risk of Injury: FDA Safety Communication

Murilo Freitas - 04:00, 24 de octubre de 2022462

Do not to use the recalled Mighty Bliss electric heating pads due to the risks of injury, including electric shocks, skin burns, rashes or irritation.

http://www.fda.gov/medical-devices/safety-communications/do-not-use-certain-mighty-bliss-electric-heating-pads-due-risk-injury-fda-safety-communication

rss-es

Mylan Institutional LLC, a Viatris Company, Issues a Voluntary Recall of One Lot of Octreotide Acetate Injection, 500 mcg/mL, Due to Glass Particulates in a Syringe

Murilo Freitas - 04:00, 24 de octubre de 2022563

Mylan Institutional LLC, a Viatris company, is voluntarily recalling lot AJ21002, exp 3/2024, of Octreotide Acetate Injection, 500 mcg/mL, packaged in a carton of ten 1mL syringes. This lot is being recalled at the user (hospital/pharmacy) level due to a product complaint of the presence of glass pa

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-institutional-llc-viatris-company-issues-voluntary-recall-one-lot-octreotide-acetate-injection

rss

La FDA busca prohibiciones judiciales permanentes contra seis fabricantes de cigarrillos electrónicos

Murilo Freitas - 20:34, 23 de octubre de 2022436

La FDA busca prohibiciones judiciales permanentes contra seis fabricantes de cigarrillos electrónicos
http://www.fda.gov/news-events/press-announcements/la-fda-busca-prohibiciones-judiciales-permanentes-contra-seis-fabricantes-de-cigarrillos

rss-es

Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System

Murilo Freitas - 04:00, 23 de octubre de 2022500

Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the WatchCare Incontinence Management System due to potential for radio frequency (RF) interference with other medical devices. The WatchCare system is designed to discreetly alert the caregiver of an inc

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-urgent-medical-device-correction-regarding-potential-radio-frequency-interference